M
$ Value
$0
Shares
4,929
Price
$0
Filed
May 27
Insider
Name
Dilsaver Evelyn S
Title
—
CIK
0001391387
Roles
Director
Transaction Details
Transaction Date
2025-05-22
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Reflects release of restricted stock units that were previously reported on a Form 4. | Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. | The restricted stock units vested on May 22, 2025.
Filing Info
Dilsaver Evelyn S's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-19 | PACS | A | $0 |
| 2025-11-24 | PACS | ▲ | $500K ★ |
| 2025-09-05 | HQY | M | $319K |
| 2025-09-05 | HQY | ▼ | $323K |
| 2025-09-05 | HQY | M | $0 |
| 2025-06-26 | HQY | A | $0 |
| 2025-05-29 | QDEL | A | $0 |
| 2025-05-24 | QDEL | A | $0 |
| 2025-05-24 | QDEL | A | $0 |
| 2025-05-24 | QDEL | M | $0 |
Other Insiders at QDEL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Blaser Brian J.
President and CEO
|
$249K | — | 2026-02-13 |
| Strobeck Matthew | $240K | — | 2026-02-13 |
|
Busky Joseph M.
Chief Financial Officer
|
$80K | — | 2026-03-28 |
|
SISITSKY NATHANIEL
Chief Legal Officer
|
— | — | 2026-04-15 |
|
Hodges Michelle A
Chief Legal Officer
|
— | — | 2026-02-08 |
|
Bowman Ronald Lee
Chief Human Resources Officer
|
— | — | 2026-01-30 |
|
Siegrist Jonathan Philip
EVP of R&D & CTO
|
— | — | 2026-01-30 |
|
McLellan Philip D.
Chief Operations Officer
|
— | — | 2026-01-31 |